Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation
- PMID: 8665850
- PMCID: PMC450174
Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation
Abstract
Interleukin-3 (IL3) was shown recently to utilize the transcription factor Stat5, but the genes regulated by this pathway and the biological consequence of Stat5 activation remained to be determined. In order to study the role of Stat5 in IL3 signalling, we constructed a dominant-negative Stat5 protein by C-terminal truncation, and inducibly expressed it in an IL3-dependent cell line. The effect of dominant-negative Stat5 induction on expression of IL3 early response genes was examined, and expression of several genes, including cis, osm and pim-1 was inhibited profoundly. The expression of c-fos was also reduced, but to a lesser extent. While activated Ras alone (though not Stat5 alone) could induce c-fos, maximal expression required the action of both Ras and Stat5. Interestingly, although the membrane-proximal region of the IL3 receptor beta-chain is responsible for both Jak2-Stat5 activation and c-myc induction, c-myc levels were not affected by the dominant-negative Stat5. Thus, the signals directed by this membrane-proximal domain, which is essential for transducing a DNA synthesis signal, can be separated further into Stat5 or c-myc pathways. The net effect of dominant-negative Stat5 expression was partial inhibition of IL3-dependent growth. This provides the first direct evidence that Stat5 is involved in regulation of cell proliferation.
Similar articles
-
IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.Oncogene. 1999 Jul 22;18(29):4191-9. doi: 10.1038/sj.onc.1202796. Oncogene. 1999. PMID: 10435632
-
Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.Oncogene. 2001 Sep 13;20(41):5826-35. doi: 10.1038/sj.onc.1204549. Oncogene. 2001. PMID: 11593388
-
STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.EMBO J. 1999 Sep 1;18(17):4754-65. doi: 10.1093/emboj/18.17.4754. EMBO J. 1999. PMID: 10469654 Free PMC article.
-
STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5.Cytokine Growth Factor Rev. 2004 Dec;15(6):435-55. doi: 10.1016/j.cytogfr.2004.09.001. Cytokine Growth Factor Rev. 2004. PMID: 15561601 Review.
-
Function and signal transduction mediated by the interleukin 3 receptor system in hematopoiesis.Stem Cells. 1996 Nov;14(6):605-18. doi: 10.1002/stem.140605. Stem Cells. 1996. PMID: 8948019 Review.
Cited by
-
Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation.Blood. 2001 May 15;97(10):3259-67. doi: 10.1182/blood.v97.10.3259. Blood. 2001. PMID: 11342457 Free PMC article.
-
A potential role of ruxolitinib in leukemia.Expert Opin Investig Drugs. 2011 Aug;20(8):1159-66. doi: 10.1517/13543784.2011.589383. Epub 2011 Jun 3. Expert Opin Investig Drugs. 2011. PMID: 21635221 Free PMC article. Review.
-
Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells.Mol Cell Biol. 1997 Jul;17(7):3663-78. doi: 10.1128/MCB.17.7.3663. Mol Cell Biol. 1997. PMID: 9199300 Free PMC article.
-
Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression.Mol Cell Biol. 1998 Apr;18(4):1996-2003. doi: 10.1128/MCB.18.4.1996. Mol Cell Biol. 1998. PMID: 9528771 Free PMC article.
-
SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation.Mol Cell Biol. 1999 Jul;19(7):4980-8. doi: 10.1128/MCB.19.7.4980. Mol Cell Biol. 1999. PMID: 10373548 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous